Atlas Trials

Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.

Clinical trial NCT01991561 · COMPLETED

Trial details

NCT number
NCT01991561
Sponsor
Medicago
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Virus DiseasesRNA Virus InfectionsRespiratory Tract DiseasesRespiratory Tract Infections
Start date
2013-06-01
Primary completion
2014-07-01
Enrollment
390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.